|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
|
|---|---|---|---|---|---|
| Current assets: | |||||
| Cash and cash equivalents | |||||
| Due from sponsor | |||||
| Prepaid expenses | |||||
| Total current assets | |||||
| Investments held in Trust Account | |||||
| Prepaid insurance – net of current portion | |||||
| Total Assets | |||||
| Current liabilities: | |||||
| Accrued expenses and accounts payable | |||||
| Due to Sponsor | |||||
| Total current liabilities | |||||
| Deferred underwriting commission | |||||
| Total liabilities | |||||
| Commitments and Contingencies | |||||
| Class A ordinary shares, $0.0001 par value; 25,300,000 shares subject to possible redemption at $10.39 and $10.21 per share at June 30, 2026 and December 31, 2025 | |||||
| Shareholders’ Deficit | |||||
| Common stock, value issued | |||||
| Accumulated deficit | |||||
| Total shareholders’ deficit | |||||
| Total Liabilities and Shareholders’ Deficit |
Loading...
